Arcus BioSciences maintains a substantial public market capitalization and corporate net worth reflecting its position as a prominent clinical-stage biopharmaceutical company focused on cancer immunotherapies. Because corporate net worth and market valuations fluctuate continuously during active trading sessions on public stock exchanges based on shifting share prices and quarterly financial reports, precise figures vary day-to-day.